Catalyst Event
10x Genomics Inc (TXG) · Earnings Release
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
5/7/2026, 12:00:00 AM
Reported Q1 2026 financial results on May 7, 2026. Revenue was $150.8 million, a 3% decrease YoY, but a 9% increase when excluding a one-time license revenue item from Q1 2025. EPS of -$0.10 beat estimates, but the stock price dropped nearly 10% following the release.
Korean Translation
2026년 5월 7일, 2026년 1분기 실적을 발표함. 매출은 1억 5,080만 달러로 전년 동기 대비 3% 감소했으나, 2025년 1분기의 일회성 라이선스 수익을 제외하면 9% 증가함. 주당순이익(EPS)은 -0.10달러로 예상치를 상회했으나, 발표 후 주가는 약 10% 하락함.
Related Recent Events
JD Health International Inc (6618) · Earnings Release
Low importance estimated as no market reaction has occurred yet; Q2 2026 earnings report scheduled.
8/12/2026, 12:00:00 AM
Livzon Pharmaceutical Group Inc (1513) · Other
Ex-dividend date on June 16, 2026, for the final dividend of RMB 1.43 per 10 shares, scheduled to be paid on July 13, 2026. Low importance estimated as the dividend amount is within historical norms, scheduled.
6/16/2026, 12:00:00 AM
Grand Pharmaceutical Group Ltd (512) · Other
Ex-dividend date (2026-06-12) for the proposed 2025 final dividend of HK$0.169 per share is scheduled.
6/12/2026, 12:00:00 AM
Veracyte Inc (VCYT) · Other
Annual Meeting of Stockholders on 2026-06-10, with proposals including the election of directors and an expansion of the 2023 Equity Incentive Plan scheduled.
6/10/2026, 12:00:00 AM
Innovent Biologics Inc (1801) · Other
Innovent will present obesity pipeline data at the ADA Scientific Sessions on June 5-8, 2026; this low-impact event is scheduled
6/5/2026, 12:00:00 AM
Pacific Biosciences of California Inc (PACB) · Other
The 2026 Annual Meeting of Stockholders is scheduled for June 3, 2026, including a proposal to increase the number of shares reserved for the 2020 Equity Incentive Plan by 16,000,000. A low impact is estimated due to potential share dilution, scheduled.
6/3/2026, 12:00:00 AM